<DOC>
	<DOCNO>NCT02197442</DOCNO>
	<brief_summary>The study open label , balance , randomize , two-treatment , four-period , two sequence , single oral dose , crossover , fully replicate bioequivalence study two formulation Valsartan 320 mg fasting condition .</brief_summary>
	<brief_title>Bioequivalence Study Valsartan 320mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>Tablet healthy , adult human subject fast condition , screen period 28 day prior dose administration Period-I . In study period , twenty-four ( 24 ) blood sample , include two ( 02 ) predose blood sample , 02 mL collect subject except discontinue / withdrawn subject analyze pharmacokinetic profile test well reference product . The pharmacokinetic parameter calculate drug concentration vs. time profile non-compartmental model use WinNonlin Professional Software-Version 5.3 ( Pharsight Corporation , USA ) Valsartan . Statistical comparison pharmacokinetic parameter two formulation carry use PROC MIXED SAS® Version 9.3 ( SAS Institute Inc. , USA ) ass bioequivalence formulation .</detailed_description>
	<mesh_term>Valsartan</mesh_term>
	<criteria>1 . Healthy , adult , human volunteer 18 45 year age ( inclusive ) live around Ahmedabad city western part India . 2 . Having Body Mass Index ( BMI ) 18.524.9 ( inclusive ) , calculate weight kg/height meter2 . 3 . Not significant disease medical history clinically significant abnormal finding screen , medical history , physical examination , laboratory evaluation , 12 lead ECG Xray chest ( P/A view ) recording . 4 . Able understand comply study procedure , opinion investigator . 5 . Able give voluntary write informed consent participation trial . 6 . In case female subject : Surgically sterilize least 6 month prior study participation ; Or If child bear potential willing use suitable effective double barrier contraceptive method intra uterine device study . And • Pregnancy test must negative . 1 . Known hypersensitivity idiosyncratic reaction valsartan formulation excipients related drug . 2 . History presence disease condition might compromise haemopoietic , renal , hepatic , endocrine , pulmonary , central nervous , cardiovascular , immunological , dermatological , gastrointestinal body system . 3 . Sitting blood pressure le 110 /70 mm Hg pulse rate le 60 100 beat per minute time screen . 4 . Presence orthostatic hypotension . 5 . If QTc interval 450 m ECG measurement time screen . 6 . Inability remain upright position time dose . 7 . Ingestion medicine ( include herbal remedy ) time within 14 day dose periodI . In case subject selection discretion Principal Investigator . 8 . Any history presence asthma ( include aspirin induce asthma ) nasal polyp NSAIDs induce urticaria . 9 . A recent history harmful use alcohol ( less 2 year ) , i.e . alcohol consumption 14 standard drink per week men 7 standard drink per week woman ( A standard drink define 360 ml beer 150 ml wine 45 ml 40 % distilled spirit , rum , whisky , brandy etc ) consumption alcohol alcoholic product within 48 hour prior receive study medicine . 10 . Smokers , smoke 10 10 cigarettes/day inability abstain smoking study . 11 . The presence clinically significant abnormal laboratory value screen . 12 . Use recreational drug history drug addiction test positive pre study drug scan . 13 . History presence psychiatric disorder . 14 . A history difficulty donate blood . 15 . Donation blood ( 1 unit 350 mL ) receipt investigational medicinal product participation drug research study within period 90 day prior first dose study medication . Elimination halflife study drug take consideration inclusion subject study . Note : In case blood loss ≤ 200 mL ; subject may dose 60 day blood donation last sample previous study . 16 . A positive hepatitis screen include hepatitis B surface antigen and/or HCV antibody . 17 . A positive test result HIV antibody . 18 . An unusual diet , whatever reason ( e.g . lowsodium ) , four week prior receive study medicine periodI . In case subject selection discretion Principal Investigator . 19 . Consumption grapefruit grapefruit product within 48 hour prior dose . 20 . Nursing mother ( female ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>